---
figid: PMC8640151__dmj-2020-0187f7
figtitle: Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic
  Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1
  Pathway
organisms:
- NA
pmcid: PMC8640151
filename: dmj-2020-0187f7.jpg
figlink: /pmc/articles/PMC8640151/figure/f7-dmj-2020-0187/
number: F7
caption: ''
papertitle: Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic
  Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1
  Pathway.
reftext: Ji-Yeon Lee, et al. Diabetes Metab J. 2021 Nov;45(6):921-932.
year: '2021'
doi: 10.4093/dmj.2020.0187
journal_title: Diabetes & Metabolism Journal
journal_nlm_ta: Diabetes Metab J
publisher_name: Korean Diabetes Association
keywords: Adipose tissue | Obesity | Sodium-glucose transporter 2 inhibitors | Thermogenesis
automl_pathway: 0.764818
figid_alias: PMC8640151__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8640151__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8640151__dmj-2020-0187f7.html
  '@type': Dataset
  description: ''
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC5A2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SIRT1
  - CD36
  - FAT1
  - MICE
---
